Steris earnings were $805.1M for the trailing 12 months ending Jun 30, 2026, with 25% growth year over year. The latest STE earnings report on Jun 30, 2026 announced Q2 2026 earnings of $200.1M, down 9.1% from last quarter. For the last reported fiscal year 2026 ending Mar 31, 2026, STE reported annual earnings of $782.3M, with 27.3% growth.
STE past earnings growth
How has STE's earnings growth performed historically?
On STE's earnings call on Aug 5, 2026, Steris (NYSE: STE) reported Q2 2026 earnings per share (EPS) of $2.05, up 13.89% year over year. Total STE earnings for the quarter were $200.10 million. In the same quarter last year, Steris's earnings per share (EPS) was $1.80.
As of the last Steris earnings report, Steris is currently profitable. Steris's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $805.10 million, a 24.53% increase year over year.
What was STE's earnings growth in the past year?
As of Steris's earnings date in Aug 5, 2026, Steris's earnings has grown 24.96% year over year. This is 29.47 percentage points higher than the US Medical Devices industry earnings growth rate of -4.51%. STE earnings in the past year totalled $805.10 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.